Found 25 matching trials
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
PHASE3The purpose of the sutdy is to evaluate the protective efficacy of Recombin...
Status
Active Not Recruiting
Location
Hebei Provincial Center for Disease Control and Prevention
Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT
PHASE4A double-blind randomized controlled trial on the safety and immunogenicity...
Location
Department of Medicine, Tuen Mun Hospital
Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above
PHASE2Herpes zoster is caused by the reactivation of latent varicella-zoster viru...
Location
Multiple Locations
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
PHASE1The purpose of this clinical study is to evaluate the safety and immunogeni...
Location
Hubei Provincial Center for Disease Control and Prevention
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above
PHASE1The purposes of the study are to evaluate the safety and tolerability of di...
Status
Active Not Recruiting
Location
Yanjin District Center for Disease Control and Prevention
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
PHASE3The purpose of the sutdy is to evaluate efficacy, safety and immunogenicity...
Status
Active Not Recruiting
Location
Hebei Provincial Center for Disease Control and Prevention
Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
PHASE1This study will compare the two vaccines that have been developed to preven...
Location
Pediatric Infectious Diseases and Clinical Trials, Universtiy of Colorado School of Medicine
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older
PHASE2This phase 2 study in China will evaluate the immunogenicity and safety of ...
Status
Active Not Recruiting
Location
Hengnan County Center for Disease Control and Prevention
A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
PHASE3This clinical trial is to study protective efficacy and safety of a recombi...
Location
Jiangsu Province Center for Disease Control and Prevention (China)
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
PHASE1This phase 1 study in China will evaluate the safety and immunogenicity of ...
Location
Guangdong Provincial Center for Disease Control and Prevention